Skip to main content

Schwab Andrew J.'s Form 4 filing

Camp4 Therapeutics CorpCAMP · filed Oct 15, 2024

Accession no.
0001104659-24-108702
Filed
Oct 15, 2024
Trade date
Oct 15, 2024
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $10.0M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schwab Andrew J.CIK 0001598549Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 15, 2024Common StockCConversionAcquired+1,337,592–F1–1,337,592Indirect
Oct 15, 2024Common StockCConversionAcquired+378,463–F3–1,716,055Indirect
Oct 15, 2024Common StockCConversionAcquired+302,770–F3–302,770Indirect
Oct 15, 2024Common StockPPurchaseAcquired+909,090$11.00+$9,999,9902,625,145Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 15, 2024Common StockCConversionDisposed−1,337,592–F1–0Indirect
Oct 15, 2024Common StockCConversionDisposed−378,463–F3–0Indirect
Oct 15, 2024Common StockCConversionDisposed−302,770–F3–0Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F3

On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)